Trial intelligence / Profile preview

Regional Analgesia Techniques (TAP vs QLB) for Pain After Cesarean Delivery

NCT03244540Phase 4Completed

Sponsor
Medical University of Lublin
Start
Sep 2017
Primary completion
Oct 2018
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Medical University of Lublin. Started Sep 2017; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03244540.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03244540.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call